ID: ALA5271388

Max Phase: Preclinical

Molecular Formula: C42H37ClN8O7S

Molecular Weight: 833.33

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCNC(=O)c1ccc(COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C42H37ClN8O7S/c1-21-22(2)59-42-34(21)36(25-11-13-27(43)14-12-25)46-29(37-49-48-23(3)50(37)42)19-33(53)44-17-18-45-38(54)26-9-7-24(8-10-26)20-58-31-6-4-5-28-35(31)41(57)51(40(28)56)30-15-16-32(52)47-39(30)55/h4-14,29-30H,15-20H2,1-3H3,(H,44,53)(H,45,54)(H,47,52,55)/t29-,30?/m0/s1

Standard InChI Key:  IRMWIHLGUKNOJM-UFXYQILXSA-N

Associated Targets(Human)

MM1.S 1111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MV4-11 7307 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/Bromodomain-containing protein 4 275 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 833.33Molecular Weight (Monoisotopic): 832.2194AlogP: 4.72#Rotatable Bonds: 11
Polar Surface Area: 194.05Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 4.21CX LogP: 3.96CX LogD: 3.96
Aromatic Rings: 5Heavy Atoms: 59QED Weighted: 0.12Np Likeness Score: -0.90

References

1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S..  (2023)  Design, synthesis, and biological evaluation of BRD4 degraders.,  78  [PMID:36563515] [10.1016/j.bmc.2022.117134]

Source